search query: @indexterm Bio-technology industry / total: 101
references: 85-94 / 101
« previous page | next page »
 titleyearauthor
85.
Sanofi: comment reussir une fusion.
Fortune France
1988 : 4FEB/2MAR, NO. 1, p. 68-71
 1988 Souske, A.
86.
Transforming Monsanto into a biotechnology-based innovator. Case study. *MONSANTO
Planning Review
1988 : JUL-AUG, VOL. 16:4, p. 28-36
 1988 Nill, K.
87.
Biotech`s baby blues.
Management Today
1988 : JAN, p. 54-60
 1988 Ferguson, A.
88.
Strategies of new biotechnology firms.
Long Range Planning
1988 : JUN, VOL. 21:3, p. 51-58
 1988 Smith, J. G.
Fleck, V.
89.
Here come the bionic piglets.
Fortune
1987 : OCT 26, VOL. 116:9, p. 72-77
 1987 Bylinski, G.
90.
UK biotechnology - which way forward?
Accountancy
1987 : AUG, VOL. 100:1128, p. 64-69
 1987 Brandenberg, M.
91.
The big boys are joining the biotech party.
Fortune
1987 : JUL 6, VOL. 116:1, p. 44-46, 48-49
 1987 Gannes, S.
92.
The financing threshold effect on success and failure of biomedical and pharmaceutical start-ups.
Management Science
1987 : MAR, VOL. 33:3, p. 381-394
 1987 Roberts, E. B.
Hauptman, O.
93.
Biotech's acquired income deficiency syndrome. ( *BIOGEN )
Business
1987 : FEB, p. 80-83
 1987 Inman, B.
94.
Patents and the biotechnological industry.
Journal of World Trade Law
1986 : NOV-DEC, VOL. 20:6, p. 705-713
 1986 Wassermann, U.
« previous page | next page »
SCIMA